NCT04065347View on ClinicalTrials.gov

Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

November 21, 2019

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions
HIV/AIDSAdherence, Medication
Interventions
DEVICE

Digital Pill

Digital Pill over encapsulating tenofovir alafenamide ART

Trial Locations (1)

80045

University of Colorado, Aurora

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Colorado, Denver

OTHER

NCT04065347 - Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF) | Biotech Hunter | Biotech Hunter